Ranitidine Bismuth Citrate

CAS: 128345-62-0

Ref. 3D-FR158426

Produktinformation

• Name: Ranitidine Bismuth Citrate
• Synonyme: 1,1-Ethenediamine, N-[2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-N′-methyl-2-nitro-, compd. with 2-hydroxy-1,2,3-propanetricarboxylic acid bismuth(3+) salt (1:1:1), 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, bismuth(3+) salt, compd. with N-[2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-N′-methyl-2-nitro-1,1-ethenediamine (1:1:1), Gastrimuto, Gr 122311X, Pylorid, Ranitidine bismutrex, Rantidinebismuthcitrate, Tritec, bismuth(3+) 2-hydroxypropane-1,2,3-tricarboxylate - (Z)-N-{2-[({5-[(dimethylamino)methyl]furan-2-yl}methyl)sulfanyl]ethyl}-N'-methyl-2-nitroethene-1,1-diamine (1:1)

Beschreibung

Ranitidine bismuth citrate is a histamine H2 receptor antagonist that has been shown to be effective in the treatment of infectious diseases. It is also used as a prophylactic agent against stress-induced ulcers, and as an adjunct in the treatment of duodenal ulceration. Ranitidine bismuth citrate has a low solubility at physiological pH values and is often formulated with citric acid or sodium bicarbonate to increase solubility. The drug's mechanism of action is not fully understood but it is believed to be due to its ability to bind histamine receptors on the surface of the stomach lining, thereby reducing acid production by parietal cells in the stomach. Ranitidine bismuth citrate may also inhibit growth factor-β1 (GF-β1) synthesis.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 712.49 g/mol
• Formel: C₁₃H₂₂N₄O₃S·C₆H₅O₇·Bi
• Reinheit: Min. 95%